|
Forecast
Period
|
2024-2028
|
|
Market
Size (2022)
|
USD
663.59 million
|
|
CAGR
(2023-2028)
|
3.95%
|
|
Fastest
Growing Segment
|
Software
& Services Segment
|
|
Largest
Market
|
Northern
& Central
|
Market Overview
Saudi Arabia In Vitro Diagnostics Market has valued
at USD 663.59 million in 2022 and is anticipated to witness an impressive
growth in the forecast period with a CAGR of 3.95% through 2028. In Vitro Diagnostics (IVD) refers to a
category of medical tests and diagnostic procedures that are performed on
biological samples taken from the human body, such as blood, urine, tissue, and
other bodily fluids or specimens, outside of the living organism. The term
"in vitro" is Latin for "in glass," and it signifies that
these tests are conducted in a controlled laboratory environment, typically in
test tubes, Petri dishes, or other laboratory equipment. IVD tests are designed
to provide critical information about a patient's health, including the
presence or absence of diseases, infections, and various medical conditions.
These tests play a vital role in disease diagnosis, monitoring, and management,
as well as in screening for early disease detection. They are used in various
healthcare settings, including hospitals, clinics, laboratories, and even at
the point of care (POC) by healthcare providers. IVD covers a broad range of
diagnostic categories, including clinical chemistry, hematology, microbiology,
immunology, pathology, genetics, and more. Each category focuses on specific
types of tests and diagnostic procedures. Samples for IVD tests can include
blood, urine, saliva, tissue, cerebrospinal fluid, and other biological
materials. The choice of sample depends on the type of test and the information
needed for diagnosis.
Like many countries, Saudi Arabia is experiencing
an aging population, which is more susceptible to health issues. This
demographic shift boosts the demand for diagnostic tests, particularly in
geriatric care. Continuous advancements in IVD technology, including molecular
diagnostics and point-of-care testing, offer more accurate and rapid testing
solutions, attracting both healthcare providers and patients. Increasing
awareness among the population about the benefits of early disease detection
and regular health check-ups is driving the demand for IVD tests. The COVID-19
pandemic accelerated the adoption of telehealth and digital health solutions.
This has created opportunities for IVD companies to offer remote diagnostic
testing and monitoring. Saudi Arabia has been increasing its healthcare
spending to enhance its healthcare infrastructure and services. This investment
provides a favorable environment for the IVD market to expand and innovate.
Key Market Drivers
Technological Advancements
Molecular
Diagnostics: This technology allows for the detection of DNA, RNA, and proteins
at the molecular level. Polymerase Chain Reaction (PCR) and Next-Generation
Sequencing (NGS) have revolutionized the diagnosis of infectious diseases,
genetic disorders, and cancer. Point-of-Care Testing (POCT) devices provide
rapid results at or near the patient's location. These devices have become
increasingly sophisticated, enabling the diagnosis of conditions like diabetes,
infectious diseases, and cardiovascular markers within minutes. Microfluidic
technology enables the manipulation of tiny amounts of fluids for testing. It
has applications in miniaturized diagnostic devices, such as lab-on-a-chip
systems, which are used for rapid, low-cost diagnostics. Immunosensors use
antibodies or antigens to detect specific molecules in biological samples. They
are widely used for diagnosing conditions like HIV, cancer, and autoimmune
diseases. Mass spectrometry allows for the precise identification and
quantification of molecules in a sample. It has applications in proteomics and
clinical chemistry, enabling the detection of various diseases and monitoring
of treatment effectiveness. Digital pathology involves scanning and analyzing
tissue samples digitally. It enhances the accuracy and speed of pathology
diagnoses, allowing for remote consultations and second opinions.
Automated systems improve efficiency and reduce
human error in diagnostic laboratories. Robots and automated sample processing
systems handle sample preparation, testing, and data analysis. AI and machine
learning are being used to analyze complex datasets from diagnostic tests. They
can aid in pattern recognition, disease diagnosis, and prediction of patient
outcomes. The revolutionary CRISPR-Cas technology has been adapted for
diagnostic purposes. It can accurately detect genetic material from pathogens, including
viruses and bacteria, in a matter of minutes. Nanotechnology has enabled the
development of nanoparticles and nanoscale diagnostic devices. These can
enhance the sensitivity and specificity of tests, making them suitable for
early disease detection. Mobile applications and digital health platforms are
being used for patient self-monitoring and data collection. Patients can use
smartphone apps to track vital signs and share data with healthcare providers.
Liquid biopsies involve the analysis of blood,
urine, or other bodily fluids to detect cancer biomarkers and genetic
mutations, enabling non-invasive cancer diagnosis and monitoring. Wearable
devices and remote monitoring tools, such as continuous glucose monitors and
ECG monitors, provide real-time data for chronic disease management. Telehealth
technology allows patients to consult with healthcare providers remotely and
receive test results and medical advice from the comfort of their homes. AR and
VR technologies can be used for medical training and visualizing diagnostic
data in three dimensions. This factor will help in the development of the Saudi
Arabia In Vitro Diagnostics Market.
Rising Aging Population
As people age, they become more susceptible to a
wide range of chronic and age-related diseases, such as cardiovascular
diseases, cancer, diabetes, and neurodegenerative disorders. This higher
disease risk necessitates frequent diagnostic testing and monitoring. Timely diagnosis of age-related health issues
is critical for effective treatment and management. IVD tests play a crucial
role in early disease detection, enabling healthcare providers to initiate
interventions before conditions become severe. Aging individuals often undergo
routine health screenings to assess their overall health, monitor chronic
conditions, and identify potential health risks. IVD tests are commonly used in
these screenings. IVD technologies, including genetic and molecular diagnostics,
are increasingly used to tailor treatments to an individual's genetic makeup
and disease profile, especially in conditions more prevalent in the elderly
population.
Many older adults take multiple medications, which
can lead to drug interactions and adverse effects. IVD tests are used to
monitor medication levels in the body and ensure proper dosing. Elderly
individuals often have multiple chronic conditions, such as hypertension,
osteoarthritis, and heart disease. Regular diagnostic tests are necessary to
manage these conditions effectively. IVD tests are integral to preventive
healthcare measures, including vaccination monitoring, cancer screenings, bone
density assessments, and heart disease risk assessment. Telehealth and remote
monitoring technologies, often used by older individuals, rely on IVD tests to
collect health data and transmit it to healthcare providers for assessment and
intervention.
IVD tests can detect aging-related biomarkers that
provide insights into an individual's health status and disease risk. With
advances in healthcare and living conditions, the aging population is living
longer. This prolonged life expectancy requires ongoing monitoring and
management of health conditions, further driving the demand for IVD. Early
diagnosis and monitoring through IVD can help prevent complications and reduce
the need for hospitalization, benefiting both patients and healthcare systems.
As the elderly population grows, the healthcare system faces increasing
demands. IVD tests can aid in optimizing healthcare resources and ensuring that
individuals receive the right care at the right time. This factor will pace up
the demand of the Saudi Arabia In Vitro Diagnostics Market.
Rising Public Awareness
Increased public awareness about the importance of
regular health check-ups and diagnostic tests encourages individuals to
proactively seek screenings for various health conditions. This leads to early
disease detection and intervention, which can significantly improve treatment
outcomes and overall health. Informed individuals are more likely to adopt a
preventive healthcare approach. They understand the value of maintaining good
health and are more inclined to undergo routine diagnostic tests, such as cholesterol
screenings, blood pressure checks, and cancer screenings, as part of preventive
healthcare. Public awareness campaigns and health education initiatives provide
information about the risks of specific diseases, the benefits of early
diagnosis, and the availability of IVD tests. This knowledge empowers
individuals to make informed decisions about their health. Public awareness
efforts often lead to the development of national or local screening programs
for conditions like cancer, diabetes, and infectious diseases. These programs
promote widespread IVD testing and make such tests accessible to a broader
population. Health education campaigns often emphasize lifestyle changes, such
as smoking cessation, healthy eating, and physical activity, that can reduce
the risk of chronic diseases. Individuals who adopt healthier lifestyles may
still undergo IVD tests for risk assessment and early detection.
Awareness of the potential benefits of genetic
testing has increased interest in understanding one's genetic predispositions
to certain diseases. This has led to greater demand for genetic IVD tests that
can provide insights into individual health risks. Public awareness about the
importance of managing chronic diseases has encouraged individuals to monitor
their conditions more closely through IVD tests. This includes individuals with
diabetes, hypertension, and cardiovascular diseases. Informed patients are
often more engaged in their healthcare. They may request specific IVD tests,
participate in shared decision-making with healthcare providers, and actively
manage their health conditions.
Advocacy groups and patient associations often play
a role in raising awareness about specific diseases and the availability of IVD
tests for early diagnosis. These groups can influence healthcare policy and
drive increased access to IVD testing. Awareness of digital health platforms
and telemedicine services has grown. Patients are increasingly comfortable with
using technology to access IVD services and consult with healthcare providers
remotely. Public awareness efforts can help reduce the stigma associated with
certain health conditions, encouraging individuals to seek testing and
treatment without fear of social judgment. Governments and healthcare
organizations may launch population health initiatives that include IVD testing
for specific health concerns, such as sexually transmitted infections or
infectious disease outbreaks. This factor will accelerate the demand of the
Saudi Arabia In Vitro Diagnostics Market.
Download Free Sample Report
Key Market Challenges
Infrastructure and Resources
Many IVD tests, especially complex molecular and
genetic tests, require advanced laboratory facilities with specialized
equipment and highly trained personnel. Establishing and maintaining such
facilities can be costly and logistically challenging. The equipment used for
IVD testing requires regular maintenance to ensure accurate and reliable
results. Regular calibration, quality control, and equipment servicing are
necessary but can be resource intensive. Highly skilled laboratory personnel,
including pathologists, clinical laboratory scientists, and medical
technologists, are required to perform and interpret IVD tests accurately.
Recruiting and retaining such professionals can be challenging. Diagnostic
tests rely on a steady supply of reagents, chemicals, and consumables. Ensuring
a consistent supply chain for these resources is crucial to maintain the
continuity of IVD services. Some diagnostic tests, especially those involving
biological samples, require specific storage conditions, including refrigeration
or deep freezing. Ensuring an uninterrupted cold chain is essential for sample
integrity.
Economic Factors
IVD tests can vary widely in cost, with some being
expensive, especially advanced molecular and genetic tests. The cost of tests
may be a barrier for patients, particularly in countries with limited
healthcare coverage. Healthcare systems, including public and private
healthcare providers, often have budget constraints. Allocating resources for
the acquisition of diagnostic equipment, reagents, and the operation of
diagnostic laboratories can be challenging, especially in resource-constrained
settings. The reimbursement landscape for diagnostic tests can be complex.
Inconsistent reimbursement policies or delays in reimbursement payments can
impact the financial viability of diagnostic laboratories and providers. The
extent of health insurance coverage for IVD tests can vary widely, affecting
patients' ability to access these tests. Limited insurance coverage may result
in higher out-of-pocket expenses for patients. Decisions regarding which
diagnostic tests to offer are often influenced by their cost-effectiveness.
Evaluating the cost-effectiveness of tests is essential, especially when
healthcare resources are limited. Socioeconomic disparities can affect the
accessibility of IVD tests. Individuals with lower incomes may face barriers to
accessing diagnostic services, resulting in delayed or missed diagnoses.
Key Market Trends
Point-of-Care Testing (POCT)
POCT enables healthcare providers to obtain test
results quickly, often within minutes. This rapid turnaround time is crucial
for making immediate clinical decisions, especially in emergency or critical
care situations. POCT improves patient care by allowing for on-the-spot
diagnosis and treatment adjustments. It reduces the need for follow-up
appointments and can lead to better patient outcomes. Traditional
laboratory-based testing often involves sample transportation and processing
delays. POCT eliminates these delays, allowing for faster diagnosis and
treatment. POCT technology is particularly valuable in remote or underserved
regions where access to centralized laboratories may be limited. It brings
diagnostic capabilities to areas with limited healthcare infrastructure. POCT
can reduce the workload on centralized laboratories, freeing up resources for
more complex or specialized testing. This is especially valuable during times
of high demand, such as disease outbreaks. Many POCT devices are designed for
ease of use and do not require specialized laboratory skills. This makes them
accessible to a wider range of healthcare providers, including non-laboratory
personnel.
Segmental Insights
Product Insights
In 2022, the Saudi
Arabia In Vitro Diagnostics Market
largest share was held by Reagent segment and is predicted to continue
expanding over the coming years. Reagents are fundamental components of
diagnostic tests. They consist of various substances, such as chemicals,
antibodies, or enzymes, that interact with patient samples to produce a
measurable signal. Nearly all IVD tests, from blood tests to molecular
diagnostics, rely on reagents for accurate and specific results. Many routine
diagnostic tests, such as blood chemistry, haematology, and immunoassays,
depend on reagents. These tests are commonly performed in healthcare settings
to assess a patient's overall health and to diagnose various medical
conditions. Reagents are crucial for testing infectious diseases, including
viral and bacterial infections. The demand for such tests, especially
considering the COVID-19 pandemic, has significantly increased the prominence
of the Reagent segment. Reagents are integral to the management of chronic
diseases such as diabetes, cardiovascular conditions, and autoimmune disorders.
Continuous monitoring of these conditions requires regular testing, which
drives the demand for reagents. Reagents are used in point-of-care testing,
which has gained importance due to its rapid results and convenience. These
tests can be performed in various healthcare settings, including clinics and
physician offices.
Application Insights
In 2022, the Saudi Arabia
In Vitro Diagnostics Market largest share was held by Cardiology segment and is
predicted to continue expanding over the coming years. Cardiovascular diseases, including heart
disease and hypertension, are major health concerns in Saudi Arabia. These
conditions are leading causes of morbidity and mortality in the country. The
high prevalence of cardiovascular diseases necessitates a significant number of
diagnostic tests for risk assessment, diagnosis, and ongoing monitoring. An aging
population is more susceptible to cardiovascular diseases. Saudi Arabia, like
many other countries, has been experiencing demographic changes with a growing
elderly population. This demographic shift has contributed to an increased
demand for cardiovascular diagnostic tests. Unhealthy lifestyle factors, such
as sedentary behaviour, poor diet, and smoking, have been on the rise in Saudi
Arabia. These factors are known contributors to heart diseases, making it
essential to diagnose and manage cardiovascular conditions. There has been an
increased awareness of the importance of cardiovascular health and the benefits
of early detection and management of heart-related conditions. This has led to
more individuals seeking diagnostic tests, especially for risk assessment and
preventive measures. The Saudi government has launched various healthcare
initiatives aimed at tackling non-communicable diseases, including
cardiovascular diseases. These initiatives often involve screening programs and
diagnostic campaigns, further boosting the demand for cardiovascular IVD tests.
End-User Insights
In 2022, the Saudi
Arabia In Vitro Diagnostics Market largest share was held by Hospitals & Clinics segment in the forecast
period and is predicted to continue expanding over the coming years. Hospitals and clinics typically serve a high
volume of patients, making them significant consumers of diagnostic tests.
These facilities handle a wide range of medical conditions, from routine
check-ups to complex medical cases, necessitating various diagnostic tests.
Hospitals, especially larger tertiary and specialized hospitals, offer a wide
array of specialized medical services. These services often require advanced
diagnostic tests, including imaging, pathology, and molecular diagnostics
Hospitals provide both inpatient and outpatient care. Inpatient care may
involve the diagnosis and monitoring of acute and chronic conditions, while
outpatient care includes routine check-ups and specialized consultations, all
of which rely on diagnostic tests. Hospitals are equipped to handle medical
emergencies. Rapid and accurate diagnostic tests are essential for triage and
immediate treatment decisions in emergency departments. Hospitals are more
likely to have advanced medical equipment and diagnostic facilities, which
allows for a broader range of diagnostic tests to be performed in-house.
Download Free Sample Report
Regional Insights
The Northern & Central region dominates the
Saudi Arabia In Vitro Diagnostics
Market in 2022. These
regions are home to some of the most densely populated cities in Saudi Arabia,
including the capital city, Riyadh, which is in the Central region. Higher
population density typically correlates with a greater demand for healthcare
services, including diagnostic testing. Northern and Central regions have a
concentration of major healthcare facilities, including hospitals, clinics, and
diagnostic centers. These healthcare institutions are more likely to offer a
wide range of diagnostic tests and services, contributing to a larger share of
the IVD market. Urban areas in these regions tend to have better healthcare
infrastructure and access to medical services. As urbanization continues to
increase, the demand for diagnostic tests grows, driven by lifestyle-related
diseases and access to better healthcare facilities. The Northern and Central
regions are economically vibrant, with a higher standard of living and greater
economic activities. This can result in increased healthcare spending and the
ability to access a broader range of medical services, including IVD tests.
These regions are more likely to host educational institutions and research centers,
which play a role in advancing medical knowledge and innovation. This
environment can lead to the adoption of the latest diagnostic technologies and
practices.
Recent Developments
- In December 2022, Quidel
Corporation and Ortho Clinical Diagnostics Holdings plc have recently announced
a definitive agreement, whereby Quidel will acquire Ortho, a major player in
the in vitro diagnostics industry. The deal involves a purchase price of $24.68
per share of Ortho's common stock, to be paid using a combination of cash and
newly issued shares in the merged entity. This offer represents a 25% premium
over Ortho's closing stock price on December 22, 2021, resulting in an equity
value of approximately $6.0 billion. The transaction is anticipated to be
completed in the first half of fiscal year 2022, pending the fulfilment of
standard closing conditions. This acquisition positions Quidel to tap into
emerging markets by leveraging telehealth technology and digital health
capabilities, all while utilizing Ortho's robust customer relationships to
enhance patient access to point-of-care diagnostic products.
Key
Market Players
- Altona Diagnostics GmbH
- Beckman Coulter, Inc.
- Siemens Healthineers AG
- OncoDNA SA
- Vela Diagnostics (Nile
Science Corporation)
- Abbott Laboratories, Inc.
- Becton, Dickinson, and
Company
- F. Hoffmann-La Roche AG
- Thermo Fischer Scientific,
Inc.
- Sysmex Corporation
|
By
Product
|
By
Technology
|
By
Application
|
By
End User
|
By
Region
|
- Instruments
- Reagent
- Software
& Services
|
- Immunoassay
- Hematology
- Clinical
Chemistry
- Molecular
Diagnostic
- Microbiology
- Others
|
- Infectious
Diseases
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Others
|
- Hospitals
& Clinics
- Diagnostic
Centers & Laboratories
- Others
|
- Eastern
- Western
- Northern
& Central
- Southern
|
Report Scope:
In this report, the Saudi Arabia In Vitro
Diagnostics Market has been segmented into the following categories, in
addition to the industry trends which have also been detailed below:
- Saudi Arabia In Vitro Diagnostics Market, By Product:
o Instruments
o Reagent
o Software & Services
- Saudi Arabia In Vitro Diagnostics Market, By Technology:
o Immunoassay
o Hematology
o Clinical Chemistry
o Molecular Diagnostic
o Microbiology
o Others
- Saudi Arabia In Vitro Diagnostics
Market, By
Application:
o Infectious Diseases
o Diabetes
o Oncology
o Cardiology
o Nephrology
o Others
- Saudi Arabia In Vitro
Diagnostics Market, By End-User:
o Hospitals & Clinics
o Diagnostic Centers & Laboratories
o Others
- Saudi Arabia In Vitro Diagnostics Market, By region:
o Eastern
o
Western
o
Northern
& Central
o
Southern
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Saudi
Arabia In Vitro Diagnostics Market.
Available Customizations:
Saudi Arabia In Vitro Diagnostics Market report with the given market data,
Tech Sci Research offers customizations according to a company's specific
needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
Saudi Arabia In Vitro Diagnostics Market is an upcoming report to be released
soon. If you wish an early delivery of this report or want to confirm the date
of release, please contact us at [email protected]